Infective Endocarditis — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Flucloxacillin IV for 4–6 weeks
MSSA tricuspid valve endocarditis in IV drug users is treated with IV flucloxacillin (or cefazolin as an equal alternative per eTG 2025 update) for 4–6 weeks. Gentamicin is no longer routinely added for native valve staphylococcal endocarditis. Vancomycin is reserved for MRSA or severe penicillin allergy.
Reference: eTG Antibiotic – 2025 – Endocarditis; ESC 2023 IE Guidelines